Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

Car manufacturers are increasingly using subscriptions and paywalled features to generate revenue, but some tactics are ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

The South Carolina Manufacturers Alliance (SCMA) has officially launched the fourth annual Manufacturing Madness: Coolest ...

It omits the type of risk information that drug manufacturers are required to provide in direct-to-consumer ads and fails to clearly disclose that compounded drugs aren’t FDA-approved ...

Duracell, one of the world’s leading battery manufacturers, unveiled its first-ever creative ad spot during the big game on Sunday. The brand shocked ...

A class-action lawsuit filed against Gore-Tex accuses the company of deceiving buyers and concealing the chemicals used in ...

CHICAGO U.S. Senate Democratic Whip Dick Durbin (D-IL) and U.S. Senator Chuck Grassley (R-IA), a senior member and former ...

HONG KONG (AP) — Asian shares Friday were mixed, with Chinese technology stocks rising as most other Asian equities declined.

The controversy stems from PhRMA's statement claiming the ad misrepresents the safety and efficacy of Hims and Hers' products and may violate marketing rules. Additionally, two US senators expressed ...